3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
HER2+ Metastatic Breast Cancer (MBC)
1
Breast Neoplasms
1
Interventions
Brentuximab Vedotin
2
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
Vinblastine
1
Specimen Handling
1
Radiotherapy
1
Radiation
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Doxorubicin
1
Dacarbazine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Hodgkin Disease
×
neratinib
×
Clear all
No trials found.